ethylketocyclazocine has been researched along with Breast Cancer in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakogeorgou, E; Castanas, E; Hatzoglou, A | 2 |
| Castanas, E; Hatzoglou, A; Kampa, M; Loukas, S; Martin, P; Martin, PM | 1 |
| Calvo, F; Castanas, E; Hatzoglou, A; Martin, PM; Panagiotou, S | 1 |
| Bakogeorgou, E; Castanas, E; Dussert, C; Hatzoglou, A; Martin, PM; Panagiotou, S; Papakonstanti, E; Stournaras, C; Wallet, F | 1 |
5 other study(ies) available for ethylketocyclazocine and Breast Cancer
| Article | Year |
|---|---|
The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors.
Topics: Adenocarcinoma; Amino Acid Sequence; Binding Sites; Breast Neoplasms; Cell Division; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Ethylketocyclazocine; Etorphine; Humans; Molecular Sequence Data; Morphine; Narcotic Antagonists; Opioid Peptides; Receptors, Opioid; Tumor Cells, Cultured | 1996 |
Identification of a novel opioid peptide (Tyr-Val-Pro-Phe-Pro) derived from human alpha S1 casein (alpha S1-casomorphin, and alpha S1-casomorphin amide).
Topics: Amino Acid Sequence; Binding, Competitive; Breast Neoplasms; Caseins; Cell Division; Cell Line; Diprenorphine; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine-2-Alanine; Enkephalins; Ethylketocyclazocine; Female; Humans; Kinetics; Peptide Fragments; Receptors, Opioid, kappa | 1996 |
Taxol inhibits opioid binding on T47D human breast cancer cells.
Topics: Amino Acid Sequence; Analgesics, Opioid; Antineoplastic Agents, Phytogenic; Binding Sites; Binding, Competitive; Breast Neoplasms; Diprenorphine; Ethylketocyclazocine; Humans; Molecular Sequence Data; Paclitaxel; Receptors, Opioid; Receptors, Opioid, kappa; Sequence Alignment; Tubulin; Tumor Cells, Cultured | 1997 |
Modulation of the estrogen-regulated proteins cathepsin D and pS2 by opioid agonists in hormone-sensitive breast cancer cell lines (MCF7 and T47D): evidence for an interaction between the two systems.
Topics: Breast Neoplasms; Cathepsin D; Cell Division; Cycloheximide; Cytosol; Diprenorphine; Dose-Response Relationship, Drug; Estradiol; Ethylketocyclazocine; Etorphine; Female; Humans; Inhibitory Concentration 50; Narcotic Antagonists; Narcotics; Neoplasms, Hormone-Dependent; Protein Synthesis Inhibitors; Proteins; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1998 |
Opioid agonists modify breast cancer cell proliferation by blocking cells to the G2/M phase of the cycle: involvement of cytoskeletal elements.
Topics: Actins; Analgesics, Opioid; Breast Neoplasms; Cytoskeleton; Ethylketocyclazocine; Etorphine; G2 Phase; Humans; Mitosis; Tumor Cells, Cultured | 1999 |